Clinical Trials Browser

Phase 1/2 × INDUSTRY × toripalimab × Clear all

NCT06975293 2026-04-17

STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas

Phase 1/2 Recruiting

Leiomyosarcoma, Liposarcoma, Sarcoma

NCT07508761 2026-04-02

IPG7236 Combined With Toripalimab in Participants With Advanced Solid Tumors

Phase 1/2 Not yet recruiting

Other solid neoplasm

Advanced Solid Tumor

NCT06953323 2026-03-27

A Phase I/II Study of WJB001 Combination Therapy on Safety and Efficacy for Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumor

NCT07281976 2026-02-12

A Trial of LBL-024 Monotherapy or Combination Drug in Patients With Triple Negative Breast Cancer

Phase 1/2 Recruiting

Triple Negative Breast Neoplasms

NCT07392736 2026-02-06

A Phase I/IIa Study of AL8326 Combined With Toripalimab in the Treatment of Advanced Solid Tumors.

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor

NCT05518045 2026-02-04

A Study of LM-108 as Monotherapy or in Combination With Antitumor Therapies in Subjects With Advanced Solid Tumors

Phase 1/2 Active not recruiting

Other solid neoplasm

Advanced Solid Tumor

NCT06771622 2026-02-04

Safety and Efficacy of HCB101 in Combination With Multiple Agents in Patients With Advanced Solid Tumors

Phase 1/2 Active not recruiting

Solid Cancer

NCT04284488 2026-01-08

Dose-escalation Study of APG-1387 and Toripalimab in Solid Tumors

Phase 1/2 Terminated

Other solid neoplasm

Advanced Solid Tumor

NCT07258979 2025-12-02

A Study of YL201 in Combination With Toripalimab and With or Without Cisplatin in Nasopharyngeal Carcinoma.

Phase 1/2 Recruiting

Nasopharyngeal Carcinoma, Recurrence

NCT06682780 2025-09-25

A Phase I/II Study of LM-2417 in Subjects With Advanced Solid Tumours

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumor

NCT06868199 2025-09-12

A Study of LM-168 as a Single Agent or in Combination With Toripalimab in Subjects With Advanced Solid Tumours

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumours

NCT07169994 2025-09-12

A Study of YL202 in Combination With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors

Phase 1/2 Recruiting

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT06088004 2025-08-22

Phase Ⅰ/Ⅱ Clinical Study to Evaluate ABO2011 in Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT06208410 2025-07-25

A Clinical Study of JS105 in Combination With Other Anti-tumor Therapies in Patients With Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT05102006 2025-06-03

A Phase Ib/II Clinical Study of LBL-007 in Combination With Toripalimab in Treatment of Advanced Malignant Tumors

Phase 1/2 Completed

Advanced Malignant Tumors

NCT04322006 2025-05-22

A Phase I/II Study of TJ004309 for Advanced Solid Tumor

Phase 1/2 Active not recruiting

Other solid neoplasm

Advanced Solid Tumor

NCT04914286 2025-05-14

A Study of GFH018 in Combination With Toripalimab in Patients With Advanced Solid Tumors

Phase 1/2 Completed

Other solid neoplasm

Advanced Solid Tumor

NCT05830539 2025-05-02

IN10018 Combination Therapy in Previously-treated Locally Advanced or Metastatic Solid Tumor Patients

Phase 1/2 Completed

Other solid neoplasm

Locally Advanced or Metastatic Solid Tumors

NCT04785196 2025-02-26

APG-115 in Combination With PD-1 Inhibitor in Patients With Advanced Liposarcoma or Advanced Solid Tumors

Phase 1/2 Recruiting

Liposarcoma

NCT05188664 2025-02-17

Study of LaNova Medicines(LM)-302 in Combination With Toripalimab in Patients With Advanced Solid Tumors

Phase 1/2 Completed

Other solid neoplasm

Advanced Solid Tumor

NCT06038396 2025-01-29

A Study of RC118 Plus Toripalimab / RC148 in Patients with Locally Advanced Unresectable or Metastatic Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumor

NCT05615974 2024-12-19

A Phase I/II Study of LM-101 Injection in Patients With Advanced Malignant Tumors

Phase 1/2 Recruiting

Neoplasms

NCT06117566 2024-11-25

A Study of WX390 Combined With Toripalimab in Patients With Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor

NCT06410703 2024-10-31

CAN1012 Combined With PD-1 in Patients With Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumor

NCT06079112 2024-09-19

9MW2821 Combined With Toripalimab Injection in Subjects With Local Advanced or Metastatic Urothelial Cancer

Phase 1/2 Recruiting

Advanced Urothelial Carcinoma

NCT05955105 2024-05-21

A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies

Phase 1/2 Recruiting

BreastDermatologicGynecologicHead & NeckSarcomaThoracic

Nasopharyngeal Carcinoma, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Melanoma, Ovarian Neoplasms, Sarcoma, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT05723432 2023-04-27

KD6001 in Combination With Anti-PD-1 Antibody in Patients With Advanced Melanoma

Phase 1/2 Unknown

Melanoma

NCT04481009 2022-12-12

A Study to Evaluate YH003 in Combination With Toripalimab (Anti-PD-1 mAb) in Subjects With Advanced Solid Tumors

Phase 1/2 Completed

Other solid neoplasm

Advanced Solid Tumors

NCT05165849 2022-05-20

A Study of GFS101A in Combination With Toripalimab in Patients With Advanced Solid Tumors

Phase 1/2 Withdrawn

Other solid neoplasm

Solid Tumor

NCT05173142 2022-03-08

HMPL-453 (FGFR Inhibitor) in Combination With Chemotherapy or Anti-PD-1 Antibody in Advanced Solid Tumors

Phase 1/2 Unknown

Gastrointestinal

Stomach Neoplasms

NCT05103917 2021-11-02

A Study to Assess the Safety, Tolerability and Antitumor Activity of X4P-001 in Combination With TNBC

Phase 1/2 Unknown

Triple Negative Breast Neoplasms